If you have been reading about clinical development and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2025-09-29. Numbers and descriptions here follow the published literature rather than marketing material.
The intended pharmacology combines three signals in one molecule. GLP-1 receptor activation reduces appetite and slows gastric emptying, effects already exploited by approved incretin-based therapies. GIP receptor engagement is associated with improved insulin sensitivity and with direct effects on adipose tissue, although how much it contributes to overall outcomes is still debated. Glucagon receptor agonism raises energy expenditure and supports hepatic lipid handling, a mechanism that also tends to increase glucose output. The triple profile is hypothesized to produce a larger metabolic effect than single or dual agonism, but the relative weight of each receptor in humans is not settled.
Human evidence remains limited to controlled studies. A phase 2 trial in adults with obesity reported large, dose-dependent reductions in body weight over 48 weeks, with gastrointestinal events as the most frequently recorded adverse effect. Phase 3 programs designated TRIUMPH, for obesity, and TRANSCEND, for type 2 diabetes, are intended to confirm efficacy and to characterize safety in larger populations. Related studies are examining conditions such as knee osteoarthritis in people with obesity and metabolic liver disease. Open questions include long-term tolerability, effects on lean mass, and what happens after treatment is stopped.
Development has progressed from single- and multiple-ascending-dose studies in healthy volunteers into larger randomized trials in adults with obesity, type 2 diabetes, and fatty liver disease. Early reports describe dose-dependent reductions in body weight and improvements in glycemic markers over treatment periods of several months. Whether the glucagon arm adds tolerability cost without added benefit is still debated. Long-term cardiovascular outcomes, effects after treatment stops, and performance in older or comorbid populations are open questions rather than settled findings. Approval status may change, so the current investigational label should be confirmed against regulatory sources.
Retatrutide is an investigational synthetic peptide developed under the code LY3437943, with a backbone derived from glucose-dependent insulinotropic polypeptide. Several non-proteinogenic residues, including alpha-aminoisobutyric acid, appear in that backbone, and a fatty diacid side chain attached through a linker extends circulation time. The molecule carries roughly thirty-nine amino acid units and a total mass near 4.7 kilodaltons. Administration is by subcutaneous injection once weekly. Published work uses both the name retatrutide and the code LY3437943.
| Property | Value | Notes |
|---|---|---|
| Compound class | Synthetic triple-agonist peptide | Single linear chain carrying three receptor activities |
| Reported molecular weight | Approximately 4731 Da | Calculated from the published sequence; sources vary slightly |
| Appearance | White to off-white lyophilized powder | Typical of purified research-grade peptides |
| Solubility | Freely soluble in water; poorly soluble in nonpolar solvents | Dissolves in aqueous buffer near neutral pH |
| Storage of dry powder | -20 °C or below, desiccated, protected from light | Avoid repeated temperature cycling |
Receptor activation produces downstream effects that differ by tissue. GLP-1 receptor signaling influences appetite regulation and insulin secretion in a glucose-dependent manner. GIP receptor activity contributes to metabolic handling of nutrients and may modulate adipose tissue. Glucagon receptor engagement raises energy expenditure and promotes hepatic lipid turnover, though the balance among these actions in humans is still being characterized. Preclinical models showed reductions in body weight and improved glycemic markers.
Clinical development has progressed through phase 2 trials in adults with obesity and type 2 diabetes, with phase 3 programs reported as ongoing. Reported outcomes include reductions in body weight and improvements in glycemic measures over defined treatment periods. Whether these effects translate into durable benefits after treatment ends remains an open question. Long-term safety data across broad populations are not yet complete, and regulatory decisions have not been announced.
Published information places retatrutide in clinical development rather than on the market as an approved therapy. Early-stage and mid-stage trials have examined tolerability and changes in body weight, and larger studies continue to report results over time. Open questions include the durability of effects after treatment stops, the composition of weight lost, and cardiovascular outcomes over long periods. Statements about definitive benefit should therefore be treated as provisional. Regulatory status varies by jurisdiction and changes as applications are reviewed.
Retatrutide is an investigational synthetic peptide designed to activate three distinct receptor systems within a single molecule. Its pharmacological profile combines activity at the glucose-dependent insulinotropic polypeptide receptor, the glucagon-like peptide-1 receptor, and the glucagon receptor. This arrangement places it within a broader class of agents often described as multi-agonists, which contrast with compounds that engage one or two targets. Research interest centers on whether simultaneous signaling produces effects that single-receptor agonists cannot achieve alone. A single molecular entity also simplifies manufacturing and delivery logistics compared with combining separate agents.
Peptides in this class degrade mainly through hydrolysis, oxidation, and aggregation. The lipid modification improves plasma residence time but can also promote self-association in aqueous solution at higher concentrations. Oxidation of methionine and deamidation of asparagine residues are common chemical liabilities that accumulate during storage. Stability studies therefore track purity loss, aggregate formation, and changes in receptor-binding potency over time under defined temperature and humidity conditions.
Solid peptide is generally held as a lyophilised powder at low temperature to slow degradation, with desiccant to limit moisture uptake. Reconstituted solutions are less stable and are usually kept refrigerated and protected from light for short periods. Repeated freeze-thaw cycles are avoided because they encourage aggregation. Laboratory handling includes work in a fume hood or laminar flow cabinet to limit inhalation and contamination. Weighing and transfer steps are performed with antistatic tools to reduce static-driven loss of fine powder.
=== Research Award (since 1986) === 2025 Tian (Autumn) Qiu 2024 Elizabeth K. Neumann 2023 Kelly Marie Hines and Stacy Malaker 2022 Gloria Sheynkman 2021 Xin Yan 2019 Eleanor Browne 2014 Kerri A. Pratt 2013 Yu Xia 2012 Ileana M. Cristea and Sharon J. Pitteri 2011 Judit Villen 2010 Sarah Trimpin 2007 Rebecca Jockusch 2006 Heather Desaire 2005 Kristina Hăkansson 2004 Lingjun Li 2003 Andrea Grottoli 2001 Deborah S. Gross 2000 Elaine Marzluff 1998 Mary T. Rodgers 1997 M. Judith Charles 1994 Kimberly A. Prather 1993 Susan Graul 1992 Vicki H. Wysocki 1991 Hilkka I. Kenttämaa 1990 Jennifer Brodbelt 1987 Susan Olesik
Although both the three- and four-star ratings specify the same storage times and same minimum temperature of −18 °C (0 °F), only a four-star freezer is intended for freezing fresh food, and may include a "fast freeze" function (runs the compressor continually, down to as low as −26 °C (−15 °F)) to facilitate this. Three (or fewer) stars are used for frozen food compartments that are only suitable for storing frozen food; introducing fresh food into such a compartment is likely to result in unacceptable temperature rises. This difference in categorization is shown in the design of the 4-star logo, where the "standard" three stars are displayed in a box using "positive" colours, denoting the same normal operation as a 3-star freezer, and the fourth star showing the additional fresh food/fast freeze function is prefixed to the box in "negative" colours or with other distinct formatting. Most European refrigerators include a moist cold refrigerator section (which does require (automatic) defrosting at irregular intervals) and a (rarely frost-free) freezer section.
The Korean War, which began in 1950, was a shock to the US military and highlighted the deficiencies in psychological warfare. In spite of this, United Nations Partisan Forces Korea operated on islands and behind enemy lines. These forces were also known as the 8086th Army Unit, and later as the Far East Command Liaison Detachment, Korea, FECLD-K 8240th Army Unit. These troops directed North Korean partisans in raids, harassment of supply lines, and the rescue of downed pilots. Experience gained in the Korean War by these units influenced the development of U.S. Army Special Forces doctrine. Special Forces were formed in 1952, initially under the U.S. Army Psychological Warfare Division headed by then Brigadier General Robert A. McClure, due to the identified need to have psychological warfare capabilities. McClure specialized in psychological warfare but had little experience in unconventional warfare, though he believed the two were inextricably linked. Special Operations Command was formed by the U.S. Army Psychological Warfare Center which was activated in May 1952. The initial 10th Special Forces Group was formed in June 1952 and was commanded by Colonel Aaron Bank who is known as the father of Special Forces. The first Executive Officer was LTC William C. Martin, Jr. The 10th SFG's formation coincided with the establishment of the Psychological Warfare School, which is now known as the John F. Kennedy Special Warfare Center and School.
== Contraindications == The glue must not get into blood vessels, as this could lead to clotting in the form of thromboembolism or disseminated intravascular coagulation, or to anaphylaxis (a severe allergic reaction).
== Commercial production == Production of nicotinamide mononucleotide in the United States as a dietary supplement was prohibited in 2022 by the FDA because it is under investigation as a pharmaceutical drug. The FDA has now rescinded this determination for the β-NMN form.
Sources: en.wikipedia.org
Camille Étienne, born 29 May 1998 in Grenoble, Auvergne-Rhone-Alpes, is a French environmental activist. A member of the duo Avant l'orage (Before the Storm), along with director Solal Moisan, she takes part in and leads acts of civil disobedience, lobbying of political and economic decision makers and raising public awareness.
A genome-wide study of convergence published in 2013 analysed 22 mammal genomes and revealed that tens of genes have undergone the same replacements in echolocating bats and cetaceans, with many of these genes encoding proteins that function in hearing and vision. Both the aye-aye lemur and the striped possum have an elongated finger used to get invertebrates from trees. There are no woodpeckers in Madagascar or Australia where the species evolved, so the supply of invertebrates in trees was large. Castorocauda, a Jurassic Period mammal and beavers both have webbed feet and a flattened tail, but are not related. Prehensile tails evolved in a number of unrelated species marsupial opossums, their Australasian cousins, kinkajous, New World monkeys, tree-pangolins, tree-anteaters, porcupines, rats, skinks and chameleons, and the salamander Bolitoglossa. Pig form, large-headed, pig-snouted and hoofs are independent in true pigs in Eurasia, peccaries in South America and the extinct entelodonts. Tapirs and pigs look much alike, but tapirs are perissodactyls (odd-toed ungulates) and pigs are artiodactyls (even-toed ungulates). Filter feeding: baleen whales like the humpback and blue whale (mammals), the whale shark and the basking shark separately, the manta ray, the Mesozoic bony fish Leedsichthys, and the early Paleozoic anomalocaridid Aegirocassis have separately evolved ways of sifting plankton from marine waters. The monotreme platypus has what looks like a bird's beak (hence its scientific name Ornithorhynchus), but is a mammal.
== R == Ronald T. Raines (born 1958), American chemist Adam Vladislavovich Rakovsky (1879–1941), Soviet physical chemist Venkatraman Ramakrishnan (born 1952), 2009 Nobel Prize in Chemistry William Ramsay (1852–1916), Scottish chemist, 1904 Nobel Prize in Chemistry C. N. R. Rao (born 1934), Indian chemist François-Marie Raoult (1830–1901), French chemist, known for Raoult's law Henry Rapoport (1918–2002), American chemist, UC Berkeley William Sage Rapson (1912–1999), South African chemist and co-author of Gold Usage Nil Ratan Dhar (1892–1986), Pioneering Indian soil chemist Ken Raymond (born 1942), American inorganic and bioinorganic chemist, UC Berkeley Prafulla Chandra Ray (1861–1944), Indian chemist Julius Rebek (born 1944), Hungarian American chemist Charles Lee Reese (1862–1940), American chemist and Chemical Director of DuPont Henri Victor Regnault (1810–1878), French chemist and physicist Tadeus Reichstein (1897–1996), chemist, 1950 Nobel Prize in Physiology or Medicine Oleg Reutov (1920-1998), soviet organic chemist Rhazes (Razi) (865–925), Persian physician, philosopher and alchemist Stuart A.
These included statements that God emits a cosmic broadcast of electromagnetic waves that living creatures can receive when their neural networks are enabled by DMT; that adding DMT allows people to see otherwise invisible spirits and guardian angels; that schizophrenia and autism result from an over-abundance of bioavailable DMT and should be unified under the term “Autiphrenia,” with those affected described as geniuses created to lead humanity; that vaporizing DMT had cured his brain cancer; that staring at the sun promotes DMT production in the pineal gland; and that DMT could cure other diseases. He invited cancer patients to his ranch in the Lake View Terrace area of Los Angeles to try the substance. In a video recorded after the cancer claim was questioned, Cantelmo stated that he had never had any form of cancer and that the reference was metaphorical, describing atheism as the “worst form of cancer.” His brother Craig and other family members confirmed he had never been diagnosed with cancer.
Sources: en.wikipedia.org
On the other hand, other than the lightest nuclides, nuclides with an odd number of protons and an odd number of neutrons (odd Z, odd N) are usually short-lived (a notable exception is neptunium-236 with a half-life of 154,000 years) because they readily decay by beta-particle emission to their isobars with an even number of protons and an even number of neutrons (even Z, even N) becoming much more stable. The physical basis for this phenomenon also comes from the pairing effect in nuclear binding energy, but this time from both proton–proton and neutron–neutron pairing. The relatively short half-life of such odd-odd heavy isotopes means that they are not available in quantity and are highly radioactive. According to the fissility rule proposed by Yigal Ronen, for a heavy element with Z between 90 and 100, an isotope is fissile if and only if 2 × Z − N ∈ {41, 43, 45} (where N = number of neutrons and Z = number of protons), with a few exceptions. This rule holds for all but fourteen nuclides – seven that satisfy the criterion but are nonfissile, and seven that are fissile but do not satisfy the criterion.
== Earliest roots == Between around 3000 and 1200 BCE, the Ancient Egyptians and Mesopotamians made contributions to astronomy, mathematics, and medicine, which later entered and shaped Greek natural philosophy of classical antiquity, a period that profoundly influenced the development of what came to be known as biology.
== Formation and maintenance == The acidic pH at the skin's surface is mainly maintained by free amino acids and α-hydroxy acids (lactic acids) excreted from sweat; free fatty acids and amino acids from sebum; and urocanic acid and pyroglutamic acid.
=== Heat of solution === Erythritol has a strong cooling effect (endothermic, or positive heat of solution) when it dissolves in water, which is often compared with the cooling effect of mint flavors. The cooling effect is present only when erythritol is not already dissolved in water, a situation that might be experienced in an erythritol-sweetened frosting, chocolate bar, chewing gum, or hard candy. The cooling effect of erythritol is very similar to that of xylitol and among the strongest cooling effects of all sugar alcohols. Erythritol has a pKa of 13.903 at 18 °C.
In 2000, it acquired Brazilian appliance maker Multibrás, owner of the brands Brastemp and Consul, including its stake in Embraco. In 2001, Inglis Ltd. changed its name to Whirlpool Canada. Whirlpool continues to market Inglis appliances to this day.
Sources: en.wikipedia.org
It is an investigational peptide that activates three hormone receptors: GIP, GLP-1 and glucagon. It is being studied mainly for obesity and type 2 diabetes, and it is not approved for any clinical use. Published information comes from controlled trials rather than from general practice.
No. As of the most recent public information it remains investigational in every jurisdiction. Material sold under this name outside trials is a research chemical, not an approved medicine. Current status should always be checked against regulator notices.
Dual agonists act on two receptors, usually GIP and GLP-1. Retatrutide adds glucagon receptor activity, which is associated with increased energy expenditure. Whether that third component adds clinically meaningful benefit over dual agonism remains an open question.
As of the mid-2020s retatrutide remains investigational and is not an approved medicine in the United States or the European Union. It has been supplied mainly to participants in clinical trials. Labels and availability can change, so regulatory listings should be checked directly.